 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
With Clinical Trials Underway, Agilent Anticipates 2014 FDA Submission for Cyto Array Platform
January 29, 2013
With Clinical Trials Underway, Agilent Anticipates 2014 FDA Submission for Cyto Array Platform
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Consumer Genetics Sales, GWAS, BlueGnome Drive Illumina Q1 Microarray Revenue Growth
April 23, 2013 / BioArray News - At JP Morgan, Affy Provides Update on Cyto FDA Submission, New Genotyping Products, Restructuring
January 15, 2013 / BioArray News - Illumina Saw 'Strong' Q4 Array Performance, Driven by Growth in HumanCore, Custom Products
January 8, 2013 / BioArray News - In Sluggish World Economy, Array Companies Encouraged by China's Fast Growing Clinical Market
November 27, 2012 / BioArray News - Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News